A Nationwide Diabetes Improvement

Total Page:16

File Type:pdf, Size:1020Kb

A Nationwide Diabetes Improvement Quality in Primary Care 2005;13:105–11 # 2005 Radcliffe Publishing International exchange ‘Diabetes in the community’: a nationwide diabetes improvement programme in primary care in Israel Margalit Goldfracht Family Physician, Head of Quality Assurance Unit, Community Medical Division, Clalit Health Services Headquarters, Tel Aviv, Israel and Department of Family Health Care, Bruce Rappaport Faculty of Medicine, The Technion, Haifa, Israel Avi Porath Head, Department of Internal Medicine ‘F’, Soroka Medical Center, Beer Sheva, Israel and Ben Gurion University of the Negev, Beer Sheva, Israel Nicky Liebermann Head, Community Medicine Division, Clalit Health Services Headquarters, Tel Aviv, Israel ABSTRACT Introduction Diabetes is a chronic disease that is register of chronic diseases, and by manual reviews on the increase, and it continues to be a challenge to of medical records. large health maintenance organisations. Results The number of diabetics who reported to Participants All the primary care providers (1500 the central register rose from 20.2/1000 (1995) to physicians and 2050 nurses) to approximately 42.3/1000 (1999). There was improvement from 150 000 diabetics nationwide participated. 1.5- to 3-fold for all care indicators. The rate of Methods A nationwide intervention using quality annual testing for HbA1c rose from 22.3% to 62.8%, improvement methods was implemented during blood pressure from 53.7% to 79.4%, and low- the years 1996–1999 in 1190 clinics. Process indi- density lipoprotein cholesterol from 22.7% to cators measured performances of various inter- 54.7%. The number of HbA1c tests/year/patient ventions at the local steering team level. Outcome rose from 0.48 to 1.84. There was no improvement indicators included the number of diabetic patients in diabetes control. reporting to the central register, the number of Conclusions We attribute the interventional pro- reported HbA1c tests, and indicators of diabetic gramme’s success to tailoring interventions to exist- care (e.g. HbA1c, fundus, feet, microalbuminuria ing working conditions, using multidisciplinary and blood pressure). Multifacet interventions in- steering teams, and multidisciplinary educational cluded guidelines, organisational changes, multi- interventions. disciplinary steering teams, continuing medical education sessions, care maps, clinical pathways, follow-up and feedback. The outcomes were meas- Keywords: diabetes, glycemic control, multifaceted ured using reports from laboratories and the central interventions, primary care, quality of care Introduction Diabetes mellitus (DM) is one of the major health has a major impact on the length and quality of life, problems in the community, with serious effects on and is the main cause of blindness, end-stage renal morbidity and mortality.1 It is a chronic disease that failure, and amputation of the lower extremities in the 106 M Goldfracht, A Porath and N Liebermann Western world.2–4 According to the results of the district steering team and the district management United Kingdom Prospective Diabetes Study (UKPDS), received annual feedback on the year’s performance, good glycaemic control may prevent or postpone which was then measured both by process indicators complications and improve the patient’s quality of (performance of organisational tasks), and by out- life.5 Monitoring, glycaemic, lipid and hypertension come indicators which consisted of follow-up of control, prevention and early detection of compli- diabetic patients according to guidelines, control of cations are, therefore, the mainstays of diabetes care.5,6 diabetes and control of related diseases.12–16 Family Clalit Health Services is the largest health organ- physicians were appointed to head the district steering isation in Israel, insuring 58% of the population teams and the central headquarters team. (3 700 000 members), including 75% of the diabetic Each year had defined goals and specified inter- patients nationwide.7 The primary care clinics treat ventions (Table 1). about 80% of Clalit’s diabetic members. Patients with uncontrolled diabetes, those who are insulin depen- dent, and patients who explicitly prefer to be treated Measurement of outcomes by diabetes specialists are referred to diabetes centres The outcomes of the programme were measured by (they comprise 20% of the diabetic population accord- three methods: ing to a 1999 internal survey). The primary care staff includes 1500 physicians; general physicians (GPs), . the annual number of diabetics in the central family physicians (excluding paediatricians), 2050 register. The central register draws data from the nurses, administrators and pharmacists. physicians’ annual manual report, the automated drugs utilisation report and hospital reports ac- In 1995, Clalit conducted a number of small 17 internal surveys. We approached 200 primary care cording to coding system ICD9 . physicians and asked them to review five records of the average number of HbA1c tests per diabetic randomly chosen diabetic patients on their list. The patient per year. The data were supplied by the results were startling: only 15–33% of the patients had Clalit laboratories and divided by the number of reported diabetic patients in that year16,18 had an HbA1c test at least once in the previous two . a manual review of individual clinical records of years, 44% had undergone blood pressure examin- 19,20 ations, 13–23% had had fundus examinations, and diabetic patients. 51% had been tested for cholesterol. Considering that the central chronic diseases register, which receives Survey methods data from the physicians’ annual reports, reported that there were 70 000 diabetic patients as of 10 December The first review of the care indicators was conducted 1995, these findings portend grave consequences to a in 1997 with 867 diabetes patients nationwide, and the sizable population. results were conveyed to the district managements. In 1996, Clalit adopted the St. Vincent Declaration, We now report the results of the second review, which and proceeded to implement its recommendations took place at the end of 1999. The inclusion criteria in all its primary care clinics.8 We inaugurated the were patients diagnosed as having diabetes prior to ‘Diabetes in the community’ programme that was 1996 and treated in the same primary care clinic from conducted during 1996–1999. Its aims were to im- 1996 until study closure in December 1999. prove diabetes detection and to enhance patient fol- In 1999, of a total of 7000 diabetes patients nation- low-up as well as control of their diabetes and adjunct wide who were chosen randomly from the central illnesses (e.g. high blood pressure, excessive choles- register, 4015 met the inclusion criteria for the current terol levels). analysis. The response rate was 82.5%: 3314 question- We now present the results of the programme in naires were filled in and 2938 (88.7%) patients were terms of the outcome indicators consisting of the successfully entered into the data processing system. number of diabetic patients reporting to the central The same indicators and variables were collected register, the number of reported HbA1c tests, the indi- retrospectively for each patient for each year, i.e. cators of diabetic care (e.g. HbA1c, fundus, feet, micro- 1995 (before the intervention programme project albuminuria and blood pressure measurements). began), 1997 and 1999. A data collection sheet was prepared containing demographic data on each participating patient, on the reviewer, and on the quality of diabetes care. The Methods patient’s demographic data included their identifi- cation number, age, the year diabetes was diagnosed, the treatment given, whether the patient was in the The interventions were divided into four groups, each care of a diabetes clinic, the number of visits to the comprising a small ‘plan-do-study-act’ cycle.9–11 Each primary care clinic, and relevant details of the primary Diabetes in the community 107 Table 1 Action plan 1996 1997 1998 Multidisciplinary steering teams Strengthening of the Strengthening of the at all levels of the organisation multidisciplinary steering teams multidisciplinary steering teams at all levels of the organisation at all levels of the organisation Representative of the Preparation of diabetes care Implementation of diabetes care programme in every primary maps in primary care maps in primary care care clinic Removal of restrictions on Local register of diabetic patients Continuous follow-up on the HbA1c, lipidogram, and in every clinic, updating of numbers of patients in central microalbumin testing central register of chronic register diseases Diabetes guidelines and their Preparation of clinical pathways Implementation of clinical distribution to every physician for treatment of diabetic patients pathways for treatment of in primary care diabetic patients in primary care Continuous communication Continuous communication Continuous communication with district steering teams with district steering teams with district steering teams Annual feedback on performance Annual feedback on performance Annual feedback on performance Compulsory continuing medical Compulsory continuing medical Compulsory continuing medical education for primary care education for primary care education for primary care providers ‘Diagnosis and follow providers ‘Oral medications for providers ‘Insulin treatment for up of diabetes patients’ type 2 diabetes’ type 2 diabetes’ Annual appraisal of the Annual appraisal of the Annual appraisal of the continuing medical
Recommended publications
  • Executive Summary Describes Some of the Fruits of the Ongoing Partnerships That Ensued
    E XECUTIVE S UMMARY February 2013 PPC G OES I NTERNATIONAL : T he Israel Healthcare Quality Partnership The Jewish Healthcare Foundation’s (JHF) longstanding commitment to health IN THIS ISSUE care that is both high quality and high value care has spurred its search for promising local, national, and international models and partnerships. Among international models, the Israeli healthcare system stands out. Identifying Opportunities to Share Best Practices 1 Spending just 8% of its Gross Domestic Product on health care (half the U.S. rate), Israel’s hybrid public-private system has achieved population health Israel Partnership outcomes that surpass those of many other western countries. Timeline 2 Intrigued, JHF led a group of twenty-three community leaders on a mission to The Fruits of Partnership 4 Israel in March 2009 to learn more. The ten-day tour of diverse Israeli healthcare facilities and meetings with providers, payers, and policy makers PPC Training Goes made it clear that JHF and its Israeli partners had much to learn from one Viral 8 another. This issue of Executive Summary describes some of the fruits of the ongoing partnerships that ensued. Speaking Engagements: PRHI’s Israel Debut 11 IDENTIFYING OPPORTUNITIES TO SHARE BEST PRACTICES The goals of JHF’s first study mission to Israel in March-April 2009 were to gather and to share breakthrough ideas for healthcare and social service 650 Smithfield Street improvement, and to learn from and with Israeli leaders in healthcare quality, Centre City Tower Suite 2400 health information technology, and innovative delivery models. Pittsburgh, PA 15222 412-586-6700 A team of JHF and PRHI (Pittsburgh Regional Health Initiative, a JHF operating [email protected] www.prhi.org arm) and twenty-three colleagues from Pittsburgh, Denver, and Chicago (specialists in healthcare delivery, finance, policy, aging, special needs, and education), discovered a healthcare system that spent half that of the U.S., on a per capita basis, and still achieved superior population health outcomes.
    [Show full text]
  • The Effect of a National Lockdown in Response to COVID-19 Pandemic on the Prevalence of Clinical Symptoms in the Population
    medRxiv preprint doi: https://doi.org/10.1101/2020.04.27.20076000; this version posted December 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . The effect of a national lockdown in response to COVID-19 pandemic on the prevalence of clinical symptoms in the population *1,2 *1,2 *1,2 *1,2,3 *1,2 1,2 Ayya Keshet ,​ Amir Gavrieli ,​ Hagai Rossman ,​ Smadar Shilo ,​ Tomer Meir ,​ Tal Karady ,​ Amit 1,2 ​ 1,2 ​ 1,2 ​1,2 ​ 1,2 ​ 4 ​ 4 Lavon ,​ Dmitry Kolobkov ,​ Iris Kalka ,​ Saar Shoer ,​ Anastasia Godneva ,​ Ori Cohen, Adam Kariv ,​ Ori Hoch ,​ ​ 4 ​ 4 ​ ​5 5 ​ 2 6 ​ 4​ Mushon Zer-Aviv ,​ Noam Castel ,​ Anat Ekka Zohar ,​ Angela Irony ,​ Benjamin Geiger ,​ Yuval Dor ,​ Dorit Hizi ,​ 7 ​ 5, 8 ​ 1,2,☨ ​ ​ ​ ​ ​ Ran Balicer ,​ Varda Shalev ,​ Eran Segal ​ ​ ​ * Equal​ contribution 1 ​ Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel. 2 ​ Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. 3 ​ Pediatric Diabetes Unit, Ruth Rappaport Children’s Hospital, Rambam Healthcare Campus, Haifa, Israel. 4 The​ public knowledge workshop, 26 Saadia Gaon st. Tel Aviv 5 ​ Epidemiology and Database Research Unit, Maccabi Healthcare Services, Tel Aviv, Israel. 6 School of Medicine-IMRIC-Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel. 7 ​ Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel. 8 ​ School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
    [Show full text]
  • Israel Endocrine Society
    Israel Endocrine Society Israel Endocrine Society Conference Browse the program for the upcoming event By Session All Sessions By ID 4 By Day Tuesday By Author Aizic, A. - 31 Now Viewing: All Sessions Note: The presenter's name is in bold Registration Tuesday Morning Date: Tuesday, April 9, 2013 Time: 7:30 AM - 8:00 AM Location: Oral Presentations I: Diabetes, Obesity and Metabolism Date: Tuesday, April 9, 2013 Time: 8:00 AM - 10:00 AM Location: Bareket Hall Session Chair: Benjamin Glaser Session Chair: Hannah Kanety 8:00 AM - AMPK corrects ER morphology and function in stressed pancreatic beta-cells via regulation of the ER resident protein DRP1 (ID: 25) Jakob Wikstrom (Israel) Tal Israeli (Israel) Etty Bachar-Wikstrom (Israel) Yafa Ariav (Israel) Erol Cerasi (Israel) Gil Leibowitz (Israel) 8:15 AM - Paradox In Metabolic Homeostasis: AHNAK Knockout Mice Are Resistant To Diet-Induced Obesity And Yet They Display Reduced Insulin Sensitivity (ID: 47) Maya Ramdas (Israel) Chava Harel (Israel) Natalia Krits (Israel) http://www.xcdsystem.com/ies2013/Program/index.cfm[05/04/2013 11:15:55] Israel Endocrine Society Michal Armoni, Rambam Medical Center (Israel) Eddy Karnieli, Institute of Endocrinology, Metabolism and Diabetes (Israel) 8:30 AM - Neonatal Wolfram syndrome: novel De-novo dominant mutation presenting as an unusual clinical phenotype (ID: 52) Abdulsalam Abu-Libdeh, Hadassah Hebrew University Hospital (Israel) 8:45 AM - Importance of maintaining redox potential balance in the development of type 2 diabetes (ID: 61) Tovit Rosenzweig,
    [Show full text]
  • Israel Network Integrates Clinical Data for 8 Million Patients
    Israel network Client Profile Clalit Health Services integrates clinical data Tel Aviv, Israel for 8 million patients OVERVIEW Case Study • One of the world’s largest HMOs/IDNs • 4.2 million clients • 5,500 beds • 14 hospitals, 1,300 clinics, 420 pharmacies • 40,000 employees, including 9,000 physicians and 11,500 nurses • 60 million primary care encounters • 2.2 million ambulatory care visits • +1 million emergency room visits • 350,000 admissions • 130,000 surgical procedures ALLSCRIPTS SOLUTIONS • Allscripts dbMotion™ • Allscripts dbMotion™ Agent +25,000 Users The desire to aggregate patient information from disparate sources, do it quickly and present it in a way that made sense to caregivers gave rise to what is now called the Ofek Network, powered by the Allscripts dbMotion™ Solution, across Clalit Health Services. It connects multiple health systems that serve +2,000,000 Israel’s 8.3 million residents. Patient records viewed per month The technology compiles a view-only patient record in less than 10 seconds, freeing physicians to spend more quality time with patients, saving money on unnecessary tests and procedures, as well as reducing the incidence of complication. Because the solution sits above existing records systems to pull information based on search parameters, no +15,000,000 Pages changes to those legacy technologies are required for implementation. viewed per month Clalit Health Services has achieved significant savings across its organization by reducing unnecessary labs and imaging studies. It also achieves better patient outcomes that occur when a provider can view the pertinent portions of a patient’s <10 Seconds Avg. records in a dashboard format, with the ability to drill down into information.
    [Show full text]
  • Supplementary Figures for “Evidence for Increased Breakthrough Rates of SARS-Cov-2 Variants of Concern in Bnt162b2 Mrna Vaccinated Individuals“
    Supplementary figures for “Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals“ Talia Kustin*1,2, Noam Harel*1,2, Uriah Finkel3, Shay Perchik3, Sheri Harari1,2, Maayan Tahor1, Itamar Caspi1, Rachel Levy1, Michael Leschinsky3, Shifra Ken Dror4, Galit Bergerzon4, Hala Gadban4, Faten Gadban4, Eti Eliassian5, Orit Shimron5, Loulou Saleh6, Haim Ben-Zvi6, Doron Amichay7,8, Anat Ben-Dor7, Dana Sagas9, Merav Strauss9, Yonat Shemer Avni10,11, Amit Huppert12,13, Eldad Kepten3, Ran D. Balicer3, Doron Nezer14*, Shay Ben-Shachar3,13*†, Adi Stern1,2† * These authors contributed equally † Corresponding authors: [email protected], [email protected] 1. The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel. 2. Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel 3. Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel 4. Clalit Health Services, Central Laboratories, Haifa and Western Galilee, Israel 5. Progenin Laboratories, Jerusalem District, Clalit Health Services, Israel 6. Microbiology lab, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel 7. Central Laboratory, Clalit Health Services, Tel Aviv, Israel 8. Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University, Beersheba, Israel 9. Microbiology Laboratory, Emek Medical Center, Afula, Israel 10. Laboratory of Clinical Virology, Soroka University Medical Center. Beersheba, Israel 11. Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel 12. The Bio-statistical and Bio-mathematical Unit, The Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel 13.
    [Show full text]
  • ISPOR Israel Chapter Annual Report 2010
    ISPOR Israel Chapter Annual Report 2010 TO: Board of Directors International Society for Pharmacoeconomics and Outcomes Research 3100 Princeton Pike, Suite 3E Lawrenceville, NJ 08648 USA PREPARED BY: Shmuel Klang, PhD Department of Pharmacy and Pharmacology Clalit Health Services Tel-Aviv, Israel Tel: 972-3- -3326 Fax: 972-3-692-3322 E-mail:[email protected] Background: The Israel Local Chapter was accepted in September 2007. The Chapter has 62 members. The current Executive Board of the Israel Local Chapter is: President Shmuel Klang, PhD (2010-2011) Clalit Health Services Headquarters Tel-Aviv, Israel Vice President Nicky Lieberman, MD (2010-2011) Clalit Health Services Headquarters Tel-Aviv, Israel Secretary Noa Triki, PhD Maccabi Healthcare Services Headquarters Tel Aviv, Israel Treasurer Barak Palatchi, BA Director Dan Greenberg, PhD Department of Health Systems Management Ben-Gurion University of the Negev Beer-Sheva, Israel Israel Chapter Annual Report 20 Director Mordi Rabinovich, MBA (PhD candidate) Strategic Consulting Services Market Access & Reimbursement Nes-Ziona, Israel Director Erez Shem-Tov, MBA Abbott Israel Tel-Aviv, Israel For more information on the Israel Chapter, please visit the ISPOR Regional Chapter website http://www.ispor.org/local_chapters/Israel/index.asp. Enclosure: ISPOR Israel Chapter Annual Report 2010 2 Israel Chapter Annual Report 20 ISPOR Israel Chapter Annual Report 2010 Activities/ Summary Accomplishments Scientific / 1 day seminar was held in the Lin regional clinic of Clalit Health Educational Services in Haifa. During the seminar, ISPOR-Israel members Activities (Shmuel Klang, Oren Shavit, Moshe Leshno, Mordi Rabinovich, and Dan Greenberg) presented various topics on methods for economic evaluations and budget impact analysis.
    [Show full text]
  • Covid-19 Vaccine Effectiveness in Healthcare Personnel in Six Israeli Hospitals (Covehpi)
    medRxiv preprint doi: https://doi.org/10.1101/2021.08.30.21262465; this version posted September 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Covid-19 Vaccine Effectiveness in Healthcare Personnel in six Israeli Hospitals (CoVEHPI) Mark A. Katz, MD1, 2, 3; Efrat Bron Harlev, MD, MPA4*; Bibiana Chazan, MD5, 6*; Michal Chowers, MD, MPH7,8*; David Greenberg, MD9, 10*; Alon Peretz, MD, MHS, MHA11*; Sagi Tshori, MD, PhD 12, 13*; Joseph Levy, PhD1; Mili Yacobi, MHA1; Avital Hirsch, MPH1; Doron Amichay , PhD, MHA14, 10; Ronit Weinberger, PhD14; Anat Ben Dor, PhD14; Elena Keren Taraday, PhD14; Dana Reznik, MSc4; Chen Barazani Chayat, PhD15; Dana Sagas, MSc16; Haim Ben Zvi, PhD17; Rita Berdinstein, PhD13, 18; Gloria Rashid, PhD19; Yonat Shemer Avni, PhD20; Michal Mandelboim, PhD21, 22; Neta Zuckerman, PhD21; Nir Rainy, PhD23; Amichay Akriv, MA1; Noa Dagan MD, PhD1, 24, 25, 26; Eldad Kepten, PhD1; Noam Barda, MD, PhD1, 24, 25, 26; and Ran D. Balicer, MD, PhD1, 2 1 Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel 2 School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel 3 University of Michigan School of Public Health, Ann Arbor, MI, USA 4Schneider Children's Medical Center of Israel, Petach Tikvah, Israel 5 Infectious Diseases and Infection Control Unit, Ha'Emek Medical Center, Afula, Israel 6 Rappaport Faculty of Medicine, Technion.
    [Show full text]
  • The Link Between Vitamin D Deficiency and Covid-19 in a Large Population
    medRxiv preprint doi: https://doi.org/10.1101/2020.09.04.20188268; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . The link between vitamin D deficiency and Covid-19 in a large population Ariel Israel, M.D., Ph.D. Assi Cicurel, M.D., M.B.A., Ilan Feldhamer, B.A. Yosef Dror Ph.D., Shmuel M Giveon, M.D., M.P.H., David Gillis, M.D., David Strich, M.D. Gil Lavie, M.D., M.H.A., M.B.A. Authors Affiliations: Division of Planning and Strategy, Clalit Health Services, Israel (Israel, Feldhamer, Lavie); Clalit Health Services, Southern District and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel (Cicurel); School of Nutrition, Faculty of Agriculture, The Hebrew University of Jerusalem, Rehovot, Israel (Dror); Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel (Gillis); Pediatric Specialist Clinic, Clalit Health services, Jerusalem District, Israel (Strich); Corresponding Author: Ariel Israel, MD, PhD Director, Department of Research and Data Division of Planning and Strategy Clalit Health Services 101 Arlozorov Street Tel Aviv 62098, Israel Telephone: +972-36948160 Email: [email protected] NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.09.04.20188268; this version posted September 7, 2020.
    [Show full text]
  • Past Recipients Hirsch Nursing Award
    Past Recipients Hirsch Nursing Award Year First Name Last Name Israel Institution North American Institution Area of Study 2017 Ali Abo Ali Rambam Medical Center New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2017 Limor Eisenberg Israel Ministry of Health New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2017 Dvora Luzon Kaplan Medical Center New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2017 Ben Rozenblit Meir Medical Center New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2016 Hilla Fighel Israel Ministry of Health Washington State Psychiatric Association of Advanced Practice Psychiatric Nurses 2016 Tmira Hefetz Clalit Health Services Washington State Psychiatric Association of Advanced Practice Psychiatric Nurses 2016 Meira Idan Psychiatric Mental Washington State Psychiatric Health Center Association of Advanced Practice Psychiatric Nurses 2016 Galit Levi Lev-Hasharon Mental Washington State Psychiatric Health Medical Center Association of Advanced Practice Psychiatric Nurses 2015 Liat Arbel Tel Aviv Sourasky Massachusetts General Pain Management Medical Center Hospital in Boston 2015 Ronit Meidan Hadassah Medical Massachusetts General Pain Management Center Hospital in Boston 2015 Hila Mendelovich Clalit Health Services Massachusetts General Pain Management Hospital in Boston 2015 Dana Oren Chaim Sheba Medical Massachusetts General Pain Management Center Hospital in Boston 2014 Limor Chen Rambam Medical Center Wexner Medical Center, Ohio Nurse Practitioner Profession
    [Show full text]
  • Surveillance of COVID-19 in Israel
    Surveillance of COVID-19 in Israel Report for week 26 ending 27-06-2020 Israel Center for Disease Control Summary: As of week 26, a slight increase was observed in respiratory morbidity among the 65+ age group. An increase was observed in the number of SARS-CoV-2-positive samples detected in the sentinel clinics. Clinical: Community clinics: A decrease was observed in the raw rates of visits to the clinics due to upper respiratory tract infections in all age groups. Hospitals (“Clalit Health Services”) A slight decrease was observed in the percentage of visits to the pediatric and internal medicine emergency departments due to pneumonia. Laboratory: On Week 26, 4 Positive patients for SARS-CoV-2 were identifird out of a total of 63 samples collected from patients visiting the sentinel clinics. The source of the positive samples is Dimona. 1 Israel Center for Disease Control ICDC-Israel Center for Disease Control Ministry of Health Ministry of Health Gertner Institute, Chaim Sheba Medical Gertner Institute, Chaim Sheba Medical Center Center, Tel Hashomer 52621 [email protected] [email protected] Tel: 03-7371500 Fax: 03-5349881 Tel: 03-7371500 Fax: 03-5349881 1. Visits to Community Clinics due to Upper Respiratory Infections (URI) On Week 25, a slight decrease was observed in the raw rate of visits to "Maccabi Health Services" community clinics due to upper respiratory infections in all age groups, and these were within the range of the season’s forecast (Figures 1 & 2). A similar picture was observed at “Clalit Health Services".
    [Show full text]
  • Health Services in Israel
    משרד העלייה והקליטה The Ministry of Aliyah and Immigrant Absorption ENGLISH שירותי בריאות Health Services in Israel 5th Edition Produced by The Publications Department Ministry of Aliyah and Immigrant Absorption 15 Rehov Hillel, Jerusalem 9458115 © All Rights Reserved Jerusalem 2014 Ida Ben Shetreet - Director, Publications Department Laura L. Woolf - Chief Editor, English Language Publications Catalogue Number: 0113014050 הופק על ידי אגף מידע ופרסום משרד העלייה והקליטה רח' הלל 15, ירושלים 9458115 © כל הזכויות שמורות ירושלים 2014 Telephone Information Center (03) 9733333 e-mail:[email protected] www.klita.gov.il הודפס על ידי המדפיס הממשלתי Special thanks to Dr. Yitzhak Berlovich, Director, Wolfson Hospital, for his assistance in updating this booklet. Produced by the Publications Department Table of Contents מבוא - מערכת הבריאות Introduction – The Health System 5 בישראל in Israel חוק ביטוח בריאות ממלכתי The National Health Insurance 6 Law משרד הבריאות The Ministry of Health 7 סל שירותי בריאות The “Basket of Health Services” 8 קופות חולים The Health Funds 10 שירותי חירום Emergency Services 21 בריאות השן Dental Care 23 בתי חולים Hospitals 24 היריון ולידה Pregnancy and Birth 25 התפתחות הילד Child Development 27 גיל הזהב Senior Citizens 28 שירותי בריאות סיעודיים Chronic Care 30 בריאות הנפש 31 Mental Health שירותים נוספים Additional Services 33 רפואה משלימה Alternative Medicine 34 שירותי משרד הבריאות Services of the Ministry of Health 34 שירותי הרשויות המקומיות Services of the Local Authorities 36 שירותי המוסד לביטוח Services of the National 37 לאומי Institute Insurance שירותי רפואה פרטית Private Health Care 37 שירותי רווחה Social Services 38 נספח 1 - זכויות החולה Appendix I – Rights of Patients 39 נספח 2 - פניות הציבור Appendix II – Complaints and 41 Legal Claims כתובות וטלפונים Useful Addresses 43 Health Services in Israel 3 4 Health Services in Israel Introduction – The Health System in Israel The defining characteristic of the health system in Israel is its governance by the National Health Insurance Law (1995).
    [Show full text]
  • The State of the Acute Care Hospitalization System in Israel: the Current Situation
    The State of the Acute Care Hospitalization System in Israel: The Current Situation Dov Chernichovsky and Roi Kfir A chapter from the State of the Nation Report 2019 Jerusalem, December 2019 Taub Center for Social Policy Studies in Israel The Taub Center was established in 1982 under the leadership and vision of Herbert M. Singer, Henry Taub, and the American Jewish Joint Distribution Committee. The Center is funded by a permanent endowment created by the Henry and Marilyn Taub Foundation, the Herbert M. and Nell Singer Foundation, Jane and John Colman, the Kolker-Saxon-Hallock Family Foundation, the Milton A. and Roslyn Z. Wolf Family Foundation, and the American Jewish Joint Distribution Committee. This paper, like all Center publications, represents the views of its authors only, and they alone are responsible for its contents. Nothing stated in this paper creates an obligation on the part of the Center, its Board of Directors, its employees, other affiliated persons, or those who support its activities. Translation: Julie Rosenzweig/Sagir International Translations Ltd. Editing and lay-out: Laura Schreiber Center address: 15 Ha’ari Street, Jerusalem, Israel Telephone: 02 5671818 Fax: 02 5671919 Email: [email protected] Website: www.taubcenter.org.il Internet edition The Acute Care Hospitalization System in Israel: The Current Situation 3 The Acute Care Hospitalization System in Israel: The Current Situation Dov Chernichovsky and Roi Kfir This study is one of two that examines the hospital system in Israel: • The Acute Care Hospitalization System in Israel: The Current Situation • The Acute Care Hospitalization System in Israel: From a Vision of Decentralization to a Centralized and Out-of-Control Reality These two complementary studies discuss a system in crisis, which reflects the situation of the health system in Israel as a whole.
    [Show full text]